Insider Trading
VERA Stock | USD 48.83 1.37 2.89% |
About 58% of Vera Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Vera Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Vera Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Vera Therapeutics stock news signals to limit their universe of possible portfolio assets.
Vera |
Filed transaction by Vera Therapeutics Executive. Insider Public Trading
Read at seekingalpha.com
Vera Therapeutics Current Investor Sentiment
Panic Vs Confidence
42
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vera Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vera Therapeutics.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentDisposing |
Vera Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vera Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vera Therapeutics Historical Investor Sentiment
Investor biases related to Vera Therapeutics' public news can be used to forecast risks associated with an investment in Vera. The trend in average sentiment can be used to explain how an investor holding Vera can time the market purely based on public headlines and social activities around Vera Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vera Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vera Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vera Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Vera Therapeutics.
Vera Therapeutics Fundamental Analysis
We analyze Vera Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Vera Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Vera Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vera Therapeutics stock to make a market-neutral strategy. Peer analysis of Vera Therapeutics could also be used in its relative valuation, which is a method of valuing Vera Therapeutics by comparing valuation metrics with similar companies.
Peers
Vera Therapeutics Related Equities
RAPT | RAPT Therapeutics | 9.82 | ||||
CNTB | Connect Biopharma | 6.19 | ||||
GLUE | Monte Rosa | 5.93 | ||||
MLYS | Mineralys Therapeutics, | 4.71 | ||||
VTYX | Ventyx Biosciences | 4.33 | ||||
ADAG | Adagene | 4.05 | ||||
ALDX | Aldeyra | 2.92 | ||||
CGEM | Cullinan Oncology | 2.51 | ||||
TARS | Tarsus Pharmaceuticals | 2.38 | ||||
ETON | Eton Pharmaceuticals | 2.33 | ||||
ACRV | Acrivon Therapeutics, | 2.31 | ||||
ANEB | Anebulo Pharmaceuticals | 2.14 | ||||
XLO | Xilio Development | 2.02 | ||||
RLYB | Rallybio Corp | 1.85 | ||||
TYRA | Tyra Biosciences | 1.78 | ||||
THRD | Third Harmonic | 1.39 | ||||
CYTK | Cytokinetics | 0.38 | ||||
EWTX | Edgewise Therapeutics | 0.37 | ||||
ANAB | AnaptysBio | 0.51 | ||||
COGT | Cogent Biosciences | 0.52 | ||||
TVTX | Travere Therapeutics | 1.89 |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |